Predicting Alzheimer's Disease and Related Dementias in Heart Failure and Atrial Fibrillation

Published:December 07, 2022DOI:



      The Framingham Heart Study Dementia Risk Score (FDRS) was developed in a general population of older persons. It is unknown how the FDRS variables predict Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) in heart failure and atrial fibrillation populations. We aimed to evaluate the predictive ability of the FDRS variables in population-based cohorts of heart failure and atrial fibrillation and to determine whether the addition of other comorbidities and risk factors improves risk prediction for AD/ADRD.


      Residents aged ≥50 years from 7 southeastern Minnesota counties with a first diagnosis of heart failure or atrial fibrillation between January 1, 2013, and December 31, 2017, were identified. Patients with AD/ADRD before or within 6 months after index atrial fibrillation or heart failure and patients who died within 6 months after index were excluded. For both cohorts, models were constructed to predict AD/ADRD after index including the variables in the FDRS. Additional comorbidities and risk factors were added to the models. For all models, c-statistics using 5-fold cross-validation were calculated.


      Among 3052 patients with heart failure (mean age 75 years, 53% male), 626 developed AD/ADRD; among 4107 patients with atrial fibrillation (mean age 74 years, 57% male), 736 developed AD/ADRD. Among patients with heart failure, the FDRS variables predicted AD/ADRD with c-statistic = 0.69. Adding comorbidities and risk factors improved the c-statistic slightly to 0.70. The FDRS variables also performed well (c-statistic = 0.73) in patients with atrial fibrillation; adding comorbidities and risk factors slightly improved performance (c-statistic = 0.75).


      The variables from the FDRS predict AD/ADRD well in both heart failure and atrial fibrillation populations. The addition of comorbidities and risk factors only modestly improved prediction, indicating that the FDRS variables are appropriate to predict AD/ADRD in patients with heart failure and atrial fibrillation.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Go AS
        • Hylek EM
        • Phillips KA
        • et al.
        Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
        JAMA. 2001; 285: 2370-2375
        • Virani SS
        • Alonso A
        • Aparicio HJ
        • et al.
        Heart disease and stroke statistics-2021 update: a report from the American Heart Association.
        Circulation. 2021; 143: e254-e743
        • Witt LS
        • Rotter J
        • Stearns SC
        • et al.
        Heart failure and cognitive impairment in the atherosclerosis risk in communities (ARIC) study.
        J Gen Intern Med. 2018; 33: 1721-1728
        • Qiu C
        • Winblad B
        • Marengoni A
        • et al.
        Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study.
        Arch Intern Med. 2006; 166: 1003-1008
        • Haring B
        • Leng X
        • Robinson J
        • et al.
        Cardiovascular disease and cognitive decline in postmenopausal women: results from the women's health initiative memory study.
        J Am Heart Assoc. 2013; 2e000369
        • Noale M
        • Limongi F
        • Zambon S
        • et al.
        Incidence of dementia: evidence for an effect modification by gender. The ILSA Study.
        Int Psychogeriatr. 2013; 25: 1867-1876
        • Rusanen M
        • Kivipelto M
        • Levalahti E
        • et al.
        Heart diseases and long-term risk of dementia and Alzheimer's disease: a population-based CAIDE study.
        J Alzheimers Dis. 2014; 42: 183-191
        • Adelborg K
        • Horvath-Puho E
        • Ording A
        • et al.
        Heart failure and risk of dementia: a Danish nationwide population-based cohort study.
        Eur J Heart Fail. 2017; 19: 253-260
        • Kalantarian S
        • Stern TA
        • Mansour M
        • Ruskin JN.
        Cognitive impairment associated with atrial fibrillation: a meta-analysis.
        Ann Intern Med. 2013; 158: 338-346
        • Miyasaka Y
        • Barnes ME
        • Petersen RC
        • et al.
        Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort.
        Eur Heart J. 2007; 28: 1962-1967
        • Alzheimer's Association
        2022 Alzheimer's disease facts and figures.
        Alzheimers Dement. 2022; 18: 700-789
        • Li J
        • Ogrodnik M
        • Devine S
        • et al.
        Practical risk score for 5-, 10-, and 20-year prediction of dementia in elderly persons: Framingham Heart Study.
        Alzheimers Dement. 2018; 14: 35-42
        • Rocca WA
        • Grossardt BR
        • Brue SM
        • et al.
        Data resource profile: expansion of the Rochester Epidemiology Project medical records-linkage system (E-REP).
        Int J Epidemiol. 2018; 47 (368-368j)
        • Rocca WA
        • Yawn BP
        • St Sauver JL
        • Grossardt BR
        • Melton 3rd, LJ
        History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population.
        Mayo Clin Proc. 2012; 87: 1202-1213
        • St Sauver JL
        • Grossardt BR
        • Leibson CL
        • et al.
        Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project.
        Mayo Clin Proc. 2012; 87: 151-160
        • Tison GH
        • Chamberlain AM
        • Pletcher MJ
        • et al.
        Identifying heart failure using EMR-based algorithms.
        Int J Med Inform. 2018; : 1-7
        • Manemann SM
        • St Sauver JL
        • Liu H
        • et al.
        Longitudinal cohorts for harnessing the electronic health record for disease prediction in a US population.
        BMJ Open. 2021; 11e044353
        • Cheng FW
        • Gao X
        • Mitchell DC
        • et al.
        Body mass index and all-cause mortality among older adults.
        Obesity (Silver Spring). 2016; 24: 2232-2239
        • Goodman RA
        • Posner SF
        • Huang ES
        • Parekh AK
        • Koh HK.
        Defining and measuring chronic conditions: imperatives for research, policy, program, and practice.
        Prev Chronic Dis. 2013; 10E66
      1. US Department of Health and Human Services. Multiple chronic conditions - a strategic framework: optimum health and quality of life for individuals with multiple chronic conditions. Available at: Accessed May 7, 2021.

      2. Centers for Medicare and Medicaid Chronic Conditions Data Warehouse (CCW). CCW Condition Algorithms. Available at: Accessed May 7, 2021.

        • Taylor Jr., DH
        • Fillenbaum GG
        • Ezell ME
        The accuracy of Medicare claims data in identifying Alzheimer's disease.
        J Clin Epidemiol. 2002; 55: 929-937
        • Crowson CS
        • Atkinson EJ
        • Therneau TM.
        Assessing calibration of prognostic risk scores.
        Stat Methods Med Res. 2016; 25: 1692-1706
        • Manemann SM
        • Knopman DS
        • St Sauver J
        • et al.
        Alzheimer's disease and related dementias and heart failure: a community study.
        J Am Geriatr Soc. 2022; 70: 1664-1672
        • Barnes DE
        • Zhou J
        • Walker RL
        • et al.
        Development and Validation of eRADAR: a tool using EHR data to detect unrecognized dementia.
        J Am Geriatr Soc. 2020; 68: 103-111
        • Alzheimer's Association
        2019 Alzheimer's disease facts and figures.
        Alzheimers Dement. 2019; 15: 321-387
        • Bradford A
        • Kunik ME
        • Schulz P
        • Williams SP
        • Singh H
        Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors.
        Alzheimer Dis Assoc Disord. 2009; 23: 306-314
        • Knopman DS
        • Petersen RC
        • Rocca WA
        • Larson EB
        • Ganguli M.
        Passive case-finding for Alzheimer's disease and dementia in two U.S. communities.
        Alzheimers Dement. 2011; 7: 53-60